Disulfide-rich macrocyclic peptides, e.g. cyclotides, represent a promising class of molecules with potential therapeutic use. Despite their potential their efficient synthesis at large scale still represents a major challenge. Here we report new chemo-enzymatic strategies using peptiligase variants, i.a. omniligase-1, for the efficient and scalable one-pot cyclization and folding of the native cyclotides MCoTI-II, kalata B1 and variants thereof as well as of the θ-defensin RTD-1. The synthesis of the kalata B1 variant T20K was successfully demonstrated at multi-gram scale. Several ligation sites for each macrocycle render this approach highly flexible and facilitate both the larger scale manufacture and the engineering of bioactive, grafte...